Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma, Head And Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00721513
What this trial is testing

Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Wake Forest University Health Sciences 20
Testing effectiveness (Phase 2)Looking for participantsNCT07016724
What this trial is testing

Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 208
Not applicableUnknownNCT03942380
What this trial is testing

Cell-free Tumor DNA in Head and Neck Cancer Patients

Who this might be right for
Head and Neck CancerHead and Neck NeoplasmsHead and Neck Squamous Cell Carcinoma+24 more
Christian von Buchwald 500
Testing effectiveness (Phase 2)Study completedNCT04939480
What this trial is testing

Window of Opportunity Study of Preoperative Immunotherapy With Atezolizumab in Local SCCHN

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
University Hospital, Essen 20
Testing effectiveness (Phase 2)Looking for participantsNCT07392580
What this trial is testing

Intralesional Chemotherapy (IC): Cisplatin + Epinephrine

Who this might be right for
Laryngeal Squamous Cell Carcinoma
University of Miami 20
Not applicableWithdrawnNCT00038038
What this trial is testing

Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole

Who this might be right for
Squamous Cell CarcinomaHead and Neck NeoplasmsMetastases, Neoplasm
M.D. Anderson Cancer Center
Early research (Phase 1)WithdrawnNCT05452408
What this trial is testing

Antitumor-B KAC PK Study

Who this might be right for
Squamous Cell Carcinoma of the Oral Cavity
Medical College of Wisconsin
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Looking for participantsNCT06943521
What this trial is testing

MT-4561 in Patients With Various Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)Esophageal Cancer+13 more
Tanabe Pharma America, Inc. 27
Testing effectiveness (Phase 2)UnknownNCT03096184
What this trial is testing

Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck Cancers

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 38
Testing effectiveness (Phase 2)Study completedNCT01218048
What this trial is testing

ERBITUX® Followed by Adjuvant Treatment With Chemoradiation and ERBITUX® for Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Robert Ferris 40
Testing effectiveness (Phase 2)Ended earlyNCT00408252
What this trial is testing

Efficacy of SU 011248 in Head And Neck Carcinoma

Who this might be right for
Recurrent DiseaseSquamous Cell Head and Neck CarcinomaPalliative Treatment
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 54
Not applicableNot Yet RecruitingNCT07797738
What this trial is testing

Prognostic Biomarkers for Patients With Human Papillomavirus (HPV) Positive Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma (OPSCC)HPVHPV Positive Oropharyngeal Squamous Cell Carcinoma
Abramson Cancer Center at Penn Medicine 30
Testing effectiveness (Phase 2)UnknownNCT03940976
What this trial is testing

Afatinib in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification (ESCC-A01)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University 40
Large-scale testing (Phase 3)Study completedNCT01265849
What this trial is testing

Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity

Who this might be right for
Squamous Cell Carcinoma of the Oral CavitySquamous Cell Carcinoma of the Soft Palate
CEL-SCI Corporation 928
Not applicableLooking for participantsNCT07178847
What this trial is testing

CDNA and Residual Disease After Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinomas

Who this might be right for
Locally Advanced Head and Neck Carcinoma
Centre Jean Perrin 59
Testing effectiveness (Phase 2)Looking for participantsNCT06640725
What this trial is testing

Study of TPEx Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the H&N

Who this might be right for
Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Groupe Oncologie Radiotherapie Tete et Cou 70
Not applicableActive Not RecruitingNCT06592716
What this trial is testing

Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?

Who this might be right for
Oropharynx CancerOropharynx Cancer, MetastaticOropharynx Cancer, Recurrent+2 more
Rigshospitalet, Denmark 200
Early research (Phase 1)Looking for participantsNCT06211335
What this trial is testing

Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Locally Recurrent Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaRefractory Head and Neck Squamous Cell Carcinoma
University of California, Davis 24
Large-scale testing (Phase 3)Study completedNCT00047008
What this trial is testing

Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Radiation Therapy Oncology Group 743
Next Page